Penny White

Penny White

President, Chief Executive Officer & Founder

  • Serial entrepreneur with over two decades of experience building companies.
  • Co-founder, President, and CEO of Better Plant Sciences Inc. (CSE: PLNT, OTCQB:VEGGF). Better Plant Sciences is a majority shareholder of NeonMind.
  • Former Director at Merus Labs Inc. (TSX:MSL)
  • Recognized in PROFIT Magazine's W100 most successful entrepreneurs. Ms. White's company was included in PROFIT's 500 fastest-growing companies in 2015 and 2016.
Robert Tessarolo

Robert Tessarolo

Executive Chairman of the Board

  • Over 25 years of experience in the pharmaceutical industry.
  • Former President, CEO, and Director of Mind Medicine Inc. (NEO:MMED). Mind Medicine was the first psychedelics company to list on a stock exchange.
  • Former President & CEO of Cipher Pharmaceuticals Inc. (TSX:CPH). Expanded the product pipeline with seven business development transactions that restored the company to positive EBITDA.
  • Former President of Watson Pharmaceuticals Canada.
  • Led integration of major mergers and acquisitions, including Warner Chilcott (~$5B global acquisition), Forest Laboratories (~$28B global acquisition), and Allergan ($66B global acquisition).
  • Former VP, General Manager Celgene US Inflammation & Immunology.

Cole Drezdoff

Director

  • Director and member of the Audit Committee of Better Plant Sciences Inc. since July 2020
  • Completed four years of full-time accounting and marketing courses at Toronto Metropolitan University at the Ted Rogers School of Management
  • Experience as a consultant in social media, sales, investor relations and business development